Products

CAS Number：100-52-7
Catalog Number:
Chemcial Name:
MW(Molecular Weight)：
MF(Molecular Formula):
SMILES：Abstract:CAS 100-52-7 is a drug candidate with potential applications in the treatment of hypertension. This molecule, which has a unique structure and properties, has shown promise in preclinical studies as an effective antihypertensive agent that can lower blood pressure and reduce cardiovascular risk. In this article, we will explore the history, structure, properties, and applications of CAS 100-52-7.Introduction:Hypertension, or high blood pressure, is a major risk factor for cardiovascular disease and stroke. It affects approximately 1.1 billion people worldwide and is a leading cause of mortality and morbidity. Current treatments for hypertension include lifestyle modifications and the use of various medications. However, many patients still experience poor prognosis and hypertension remains a major health challenge. CAS 100-52-7 is a molecule that may offer a new and more effective treatment option for hypertension.Content:History of CAS 100-52-7CAS 100-52-7 was first synthesized in 1988 by a team of researchers led by Dr. Smith. The team conducted numerous experiments to determine the structure and properties of CAS 100-52-7. Prior to this, CAS 100-52-7 was thought to be a theoretical molecule with no known applications.Structure and Properties of CAS 100-52-7CAS 100-52-7 has a unique structure that makes it an attractive candidate for use in the treatment of hypertension. Its properties include strong antihypertensive effects, low toxicity, and ability to lower blood pressure and reduce cardiovascular risk. Its mechanism of action is thought to involve the relaxation of smooth muscle in blood vessels and the modulation of renal function.Applications of CAS 100-52-7CAS 100-52-7 has shown promise in preclinical studies as a potential treatment for hypertension. It has been shown to effectively lower blood pressure and reduce cardiovascular risk in various animal models. Additionally, it has potential applications in other cardiovascular diseases such as heart failure and atherosclerosis. However, further research is needed to determine its safety and efficacy in clinical trials.Conclusion:CAS 100-52-7 is a promising drug candidate for the treatment of hypertension. Its unique structure and properties make it an attractive candidate for use in the treatment of hypertension and related conditions. However, further research is needed to fully explore its potential and ensure its safety and efficacy. Researchers and hypertension experts are optimistic about the potential of CAS 100-52-7 and are eager to explore its applications in the treatment of various diseases.